New Insights in Bladder Cancer Diagnosis: Urinary miRNAs and Proteins

Bladder cancer is the 10th-most common cancer worldwide. The diagnosis and follow-up of patients require costly invasive methods and due to these expenses, bladder cancer continues to be one of the expensive malignancies. Early diagnosis is crucial in bladder cancer as it is in other cancers; theref...

Full description

Bibliographic Details
Main Authors: Gökçe Güllü Amuran, Irem Peker Eyuboglu, Ilker Tinay, Mustafa Akkiprik
Format: Article
Language:English
Published: MDPI AG 2018-12-01
Series:Medical Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3271/6/4/113
_version_ 1818138221511442432
author Gökçe Güllü Amuran
Irem Peker Eyuboglu
Ilker Tinay
Mustafa Akkiprik
author_facet Gökçe Güllü Amuran
Irem Peker Eyuboglu
Ilker Tinay
Mustafa Akkiprik
author_sort Gökçe Güllü Amuran
collection DOAJ
description Bladder cancer is the 10th-most common cancer worldwide. The diagnosis and follow-up of patients require costly invasive methods and due to these expenses, bladder cancer continues to be one of the expensive malignancies. Early diagnosis is crucial in bladder cancer as it is in other cancers; therefore, non-invasive biomarkers for early diagnosis are very important. In this review, we aimed to focus on the most recent investigations on potential urinary micro RNA (miRNA) and protein biomarkers for bladder cancer diagnosis and their associated pathways. Studies performed by different groups were compiled and the biomarker properties of various proteins and miRNAs in the urine of bladder cancer patients were evaluated. Key studies were obtained by searching keywords &#8220;bladder cancer, urinary miRNA, urinary protein, urinary biomarker&#8222;. Targets and the pathways of the miRNAs and proteins were analyzed according to mirBase Catalogue and Panther Database. The major pathways that are targeted by aberrantly expressed miRNAs are Cholecystokinin receptor (<i>CCKR</i>), <i>p53</i>, <i>Wnt</i> signaling pathway, and feedback loops. We hereby conclude that urinary micro RNAs and proteins are promising candidates for bladder cancer diagnosis. It should be noted that urine collection, storage conditions, choice of fraction, and normalization strategies should be standardized.
first_indexed 2024-12-11T10:08:45Z
format Article
id doaj.art-be3175330ce548fa845b12c24148a5ba
institution Directory Open Access Journal
issn 2076-3271
language English
last_indexed 2024-12-11T10:08:45Z
publishDate 2018-12-01
publisher MDPI AG
record_format Article
series Medical Sciences
spelling doaj.art-be3175330ce548fa845b12c24148a5ba2022-12-22T01:11:50ZengMDPI AGMedical Sciences2076-32712018-12-016411310.3390/medsci6040113medsci6040113New Insights in Bladder Cancer Diagnosis: Urinary miRNAs and ProteinsGökçe Güllü Amuran0Irem Peker Eyuboglu1Ilker Tinay2Mustafa Akkiprik3Department of Medical Biology, School of Medicine, Marmara University, Istanbul 34899, TurkeyDepartment of Medical Biology, School of Medicine, Marmara University, Istanbul 34899, TurkeyDepartment of Urology, School of Medicine, Marmara University, Istanbul 34854, TurkeyDepartment of Medical Biology, School of Medicine, Marmara University, Istanbul 34899, TurkeyBladder cancer is the 10th-most common cancer worldwide. The diagnosis and follow-up of patients require costly invasive methods and due to these expenses, bladder cancer continues to be one of the expensive malignancies. Early diagnosis is crucial in bladder cancer as it is in other cancers; therefore, non-invasive biomarkers for early diagnosis are very important. In this review, we aimed to focus on the most recent investigations on potential urinary micro RNA (miRNA) and protein biomarkers for bladder cancer diagnosis and their associated pathways. Studies performed by different groups were compiled and the biomarker properties of various proteins and miRNAs in the urine of bladder cancer patients were evaluated. Key studies were obtained by searching keywords &#8220;bladder cancer, urinary miRNA, urinary protein, urinary biomarker&#8222;. Targets and the pathways of the miRNAs and proteins were analyzed according to mirBase Catalogue and Panther Database. The major pathways that are targeted by aberrantly expressed miRNAs are Cholecystokinin receptor (<i>CCKR</i>), <i>p53</i>, <i>Wnt</i> signaling pathway, and feedback loops. We hereby conclude that urinary micro RNAs and proteins are promising candidates for bladder cancer diagnosis. It should be noted that urine collection, storage conditions, choice of fraction, and normalization strategies should be standardized.https://www.mdpi.com/2076-3271/6/4/113bladder cancerurinary biomarkersmicro RNA (miRNAs)urinary proteinscholecystokinin receptor pathway<i>p53</i> pathway
spellingShingle Gökçe Güllü Amuran
Irem Peker Eyuboglu
Ilker Tinay
Mustafa Akkiprik
New Insights in Bladder Cancer Diagnosis: Urinary miRNAs and Proteins
Medical Sciences
bladder cancer
urinary biomarkers
micro RNA (miRNAs)
urinary proteins
cholecystokinin receptor pathway
<i>p53</i> pathway
title New Insights in Bladder Cancer Diagnosis: Urinary miRNAs and Proteins
title_full New Insights in Bladder Cancer Diagnosis: Urinary miRNAs and Proteins
title_fullStr New Insights in Bladder Cancer Diagnosis: Urinary miRNAs and Proteins
title_full_unstemmed New Insights in Bladder Cancer Diagnosis: Urinary miRNAs and Proteins
title_short New Insights in Bladder Cancer Diagnosis: Urinary miRNAs and Proteins
title_sort new insights in bladder cancer diagnosis urinary mirnas and proteins
topic bladder cancer
urinary biomarkers
micro RNA (miRNAs)
urinary proteins
cholecystokinin receptor pathway
<i>p53</i> pathway
url https://www.mdpi.com/2076-3271/6/4/113
work_keys_str_mv AT gokcegulluamuran newinsightsinbladdercancerdiagnosisurinarymirnasandproteins
AT irempekereyuboglu newinsightsinbladdercancerdiagnosisurinarymirnasandproteins
AT ilkertinay newinsightsinbladdercancerdiagnosisurinarymirnasandproteins
AT mustafaakkiprik newinsightsinbladdercancerdiagnosisurinarymirnasandproteins